REFERENCES
1.Hwang YM., Lee BI., Chung JW., Ahn JH., Kim KW., Kim DI. A case of herpes zoster myelitis. J Korean Neurol Assoc. 1988. 6:272–277.
2.Gilden D., Cohrs RJ., Mahalingam R., Nagel MA. Varicella zoster virus vasculopathies: diverse clinical manifestation, laboratory features, pathogenesis, and treatment. Lancet Neurol. 2009. 8:731–740.
3.Nagel MA., Cohrs RJ., Mahalingam R., Wellish MC., Forghani B., Schiller A, et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology. 2008. 70:853–860.
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
4.Haanpää M., Dastidar P., Weinberg A., Levin M., Miettinen A., Lapinlampi A, et al. CSF and MRI finding in patients with acute herpes zoster. Neurology. 1998. 51:1405–1411.
5.Umehara T., Sengoku R., Mitsumura H., Mochio S. Neurological picture. Findings of segmental zoster paresis on MRI. J Neurol Neurosurg Psychiatry. 2011. 82:694.
Figure 1.
Sagittal and axial images of cervical MRI. MRI performed 10 days after symptom onset showed focal high signal intensity in the C5-6 level on T2 weighted image (T2WI) (A, B) with focal enhancement (C, D). The lesion was improved on T2WI (E, F) and was not enhanced after gadolinium injection (G, H) 3 months later.
![kjcn-15-74f1.tif](/upload/SynapseXML/1208kjcn/thumb/kjcn-15-74f1.gif)